DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Hughes R, Dalakas MC, Merkies I. , et al; FORCIDP Trial Investigators.
Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial.
Lancet Neurol 2018;
17 (08) 689-698
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.